Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neonatology ; 109(3): 195-202, 2016.
Article in English | MEDLINE | ID: mdl-26780734

ABSTRACT

BACKGROUND: Neonates with Down syndrome (DS) weigh less, are smaller and have increased first-year mortality, especially if born small for gestational age (GA). DS-specific GA-related neonatal anthropometrics for Germany are lacking. OBJECTIVES: To construct reference tables and centile curves for birth weight (g), crown-heel length (cm) and head circumference (cm) by sex and GA for German DS neonates. METHODS: Retrospective anthropometric data from live-born singleton DS neonates born in Germany from January 1966 to June 2010 were collected using standardized questionnaires and patient records. Reference tables were created based on means and standard deviations. The 3rd, 10th, 25th, 50th, 75th, 90th and 97th centile curves were constructed and smoothed using running medians and Cole's LMS method. RESULTS: Anthropometric measurements were obtained for 1,304 DS neonates [males/females: 713/591 (54.7%/45.3%)]. Reference tables and centile charts were constructed from 3,542 (males/females: 1,932/1,610) observations for GA 32-41 weeks. Compared with general-population newborns, prematurity was increased (21.1 vs. 6.3%) at GA 32-36 weeks. Term-born (GA 40 weeks) male and female DS neonates were 352.5 and 223.5 g lighter and 1.5 and 1.4 cm smaller than general-population neonates, and head circumference was also 1.4 and 1.5 cm smaller, respectively. CONCLUSION: This is the first study to report GA-related, sex-specific reference tables and centile charts of birth weight, length and head circumference for DS neonates born in Germany. Compared with the general German population, DS newborns are more frequently born prematurely, weigh less, are smaller and have a smaller head circumference at birth.


Subject(s)
Body Weights and Measures/methods , Down Syndrome/diagnosis , Gestational Age , Neonatal Screening/methods , Body Weights and Measures/standards , Cephalometry , Female , Germany , Humans , Infant, Newborn , Male , Neonatal Screening/standards , Pregnancy , Reference Values , Retrospective Studies
2.
J Pediatr Endocrinol Metab ; 21(9): 837-45, 2008 09.
Article in English | MEDLINE | ID: mdl-18924577

ABSTRACT

Obesity can cause insulin resistance and cardiovascular and liver disease. The aim of this study was to analyze changes in laboratory values, body composition, and physical fitness before and after a one-year weight loss program with nutritional education, psychological care, and physical exercise. Twenty-two obese children (16 boys, 6 girls; median age 11.9 [range 7-15] years; BMI SDS +2.4 [1.6-3.1]) participated in the program. Outcome measures included liver enzymes, insulin resistance (HOMA), lipids, body composition, physical strength and endurance. All children had an inverse HOMA/body composition correlation; Group 1 (reduced BMI SDS after one year) had lower triglycerides, liver enzymes and improved body composition and fitness (p < 0.05). Group 2 (unchanged or increased BMI SDS) had worse body composition and increased endurance and strength of trunk extension (p < 0.05). Weight loss reduced risk factors for liver disease and improved insulin sensitivity. Body composition proved useful as a non-invasive indicator for insulin sensitivity.


Subject(s)
Body Composition/physiology , Insulin Resistance/physiology , Lipid Metabolism/physiology , Liver Diseases/epidemiology , Obesity/therapy , Physical Fitness/physiology , Weight Loss/physiology , Adolescent , Body Mass Index , Child , Diet , Exercise/physiology , Female , Humans , Liver Diseases/enzymology , Liver Diseases/prevention & control , Male , Obesity/physiopathology , Obesity/psychology , Outcome Assessment, Health Care , Physical Endurance/physiology , Program Evaluation , Risk Factors
3.
Eur J Pediatr ; 167(7): 793-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17763869

ABSTRACT

BACKGROUND: Findings have been inconsistent regarding the effect of T1DM (type 1 diabetes) on age at menarche. OBJECTIVE: The purpose was to investigate in young German women with T1DM menarcheal age and factors potentially affecting menarche, including glycemic control, BMI (body mass index), relative T1DM duration (proportion of life with diabetes), insulin dose, and insulin therapy intensity. Initiated in 1990, the DPV program is an ongoing, prospective long-term longitudinal follow-up study to benchmark the quality of care provided to pediatric and, more recently, adult diabetes patients. Two hundered two German diabetes centers participated in nationwide data collection. Based on ethnicity and the availability of menarche and T1DM onset data as the main inclusion criteria, 643 young German women were selected from 11,629 female T1DM patients aged <20 years, recruited by referral, clinic or hospital ascertainment, or self report. Mean age at menarche (+/-SD) was 13.22 +/- 1.31 years, representing a delay of 0.52 years (p < 0.001) relative to the general population. Significant delay (p < 0.05) was also found for relative T1DM duration, BMI SD score, insulin dose, and HbA1c level, with a 1% increase in HbA1c resulting in a delay in menarche by 0.07 years. CONCLUSIONS: Age at menarche is delayed in type 1 diabetes mellitus. The delay increases with relative T1DM duration and poor quality of glycemic control.


Subject(s)
Aging/physiology , Diabetes Mellitus, Type 1/complications , Puberty, Delayed/complications , Adolescent , Adult , Body Mass Index , Cross-Sectional Studies , Data Collection , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/drug therapy , Female , Germany , Glycated Hemoglobin , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Insulin/administration & dosage , Insulin/therapeutic use , Linear Models , Menarche
4.
Eur J Endocrinol ; 157(5): 647-53, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17984245

ABSTRACT

OBJECTIVE: To investigate the effect of type 1 diabetes on pubertal onset and development, and to identify factors potentially affecting puberty, including glycemic control, relative diabetes duration, body mass index standard delta score (BMI SDS), insulin dose, and intensity of insulin therapy. RESEARCH DESIGN AND METHODS: Initiated in 1990, the Diabetes-Patienten-Verlaufsdaten (DPV) is an ongoing, prospective longitudinal follow-up program to benchmark the quality of diabetes care provided to, predominantly, pediatric patients. Data collection for this non-interventional audit was carried out at 202 German diabetes treatment centers. Patient recruitment was done by referral, clinic/hospital ascertainment, or self-report. Data were analyzed for subcohorts of 1218-2409 boys and 579-2640 girls from a cohort of 24 385 pediatric type 1 diabetic patients. Selection was based on ethnicity and availability of data on Tanner stage 2, or higher, of genital and pubic hair development (boys) or breast and pubic hair development, and menarche (girls). RESULTS: Boys showed significant (P<0.05) delay (years) in mean ages at onset of genital development (12.0 (+/-0.9) years) and pubarche (12.2 (+/-0.4) years). In girls, mean ages at thelarche (11.4 (+/-0.5) years), pubarche (11.5 (+/-0.1) years), and menarche (13.2 (+/-0.5) years) were significantly delayed compared with the general population. Sexual maturity (Tanner stage 5) was not delayed in either sex. Elevated glycohemoglobin and decreased BMI SDS were associated with significantly delayed pubertal onset, whereas relative diabetes duration and insulin dose were not. CONCLUSIONS: Pubertal onset, but not sexual maturity, is delayed in children with type 1 diabetes. Delay increases with higher glycohemoglobin and lower BMI SDS.


Subject(s)
Child Development , Diabetes Mellitus, Type 1/epidemiology , Puberty, Delayed/epidemiology , Adolescent , Child , Child Development/physiology , Cross-Sectional Studies , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Disease Management , Female , Germany , Humans , Longitudinal Studies , Male , Menarche/blood , Prospective Studies , Puberty/blood , Puberty, Delayed/blood , Puberty, Delayed/etiology
5.
Biochem Biophys Res Commun ; 330(3): 805-12, 2005 May 13.
Article in English | MEDLINE | ID: mdl-15809068

ABSTRACT

AT1 receptor expression is mainly regulated posttranscriptionally involving modulation of RNA stability which is dependent on protein binding to the cognate sequence bases 2179-2195 within the 3' untranslated region of the AT1 receptor RNA. This region contains an AUUUUA hexamer which forms part of a stem-loop structure. To clarify the significance of the AUUUUA hexamer for AT1 receptor mRNA regulation, mutations were introduced inside, up- or downstream of it. In vitro decay assays, transfection experiments, and UV-light mRNA protein crosslink assays could demonstrate that mutations within the AUUUUA hexamer disrupted AT1 receptor mRNA degradation as well as the binding of polysomal proteins. In contrast, modification in the neighboring sequence had no effect on mRNA turnover or protein binding. Computer modelling revealed that the AUUUUA hexamer is important for the formation of a stem-loop structure which in turn is relevant for mRNA-protein interactions. These findings indicate that the AUUUUA hexamer is essential for the posttranscriptional modulation of the AT1 receptor mRNA expression.


Subject(s)
Gene Expression Regulation/genetics , RNA Stability/genetics , Receptor, Angiotensin, Type 1/genetics , 3' Untranslated Regions/chemistry , 3' Untranslated Regions/genetics , 3' Untranslated Regions/metabolism , Animals , Base Sequence , Cells, Cultured , Molecular Sequence Data , Muscle, Smooth, Vascular/metabolism , Mutation/genetics , Nucleic Acid Conformation , RNA, Messenger/chemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...